Longport, Inc. Announces Study for Improved Detection of Pressure Ulcers

Longport, Inc. (OTCBB:LPTI), a medical technology
specialist in high frequency high resolution ultrasound imaging, today
announced the implementation of a clinical study at two Montana
skilled nursing care centers in partnership with the Goodman Group.
   The principal investigator, Dr. Karen Zulkowski, will explore the
use of Longport's EPISCAN I-200 for improved clinical detection of
pressure ulcer risk and development. Dr. Zulkowski is a professor of
nursing at Montana State University-Bozeman and is a member of the
National Pressure Ulcer Advisory Panel (NPUAP).
   Dr. Zulkowski said, "Current practice involves the examination of
a patient's skin for signs of pressure ulcers by sight. The use of
this new technology will allow health care practitioners to identify
and treat tissue damage much earlier, well before we can see changes
on the skin's surface. This research is a wonderful opportunity for
Montana to be a leader in the use of this groundbreaking technology."
   Valley Health Care and Rehabilitation Center and Billings Health
and Rehabilitation Community, operated by the Goodman Group, have been
assets to the Billings health care community for more than 35 years.
The hallmarks of the skilled nursing centers go beyond the gracious
living spaces provided for residents, updating the communities to stay
in tune with modern care philosophies and changing healthcare
technology has always been a priority for both communities.
   Karen Powers of the Goodman Group said, "We are always ready to be
the leading innovators in long term care, the communities continually
look ahead to new care technologies that could enhance residents'
lives. Long known for its special staffing and attention in wound care
management, Valley Health and Billings Health are happy to partner
with Longport Inc to pilot a new program for preventative wound care
management."
   For more information on any of these programs please contact
Valley Health Care and Rehabilitation Center at 406-656-5010 or
Billings Health and Rehabilitation Community at 406-656-6500.
   Connie Phillips-Jones, Director of Clinical Support said, "This
initiative is a part of Longport, Inc.'s strategy of gathering
clinical study data to open new markets for our technology using
evidence-based information."

   About Longport, Inc.

   Longport, Inc. of Glen Mills, Pennsylvania, is a medical
technology company that specializes in high resolution ultrasound
imaging. After several years and a multi-million dollar investment in
the technology, Longport has secured patents, copyrights, and FDA
permission to market. The Company's technology has been used to
engineer a unique high resolution ultrasound imaging system. For
further information please contact Longport, Inc. at 1-800-289-6863 or
visit our website at www.longportinc.com.

   Forward-looking Information and the Private Securities Litigation
Reform Act of 1995

   Certain statements in this press release, including statements
concerning product development milestones and anticipated events, are
"forward-looking statements" within the Private Litigation Reform Act
of 1995. Forward Looking Statements are based on the opinions and
estimates of management at the time the statements are made and are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those anticipated in the
forward-looking statements. The words "believe," "expect," "intend,"
"anticipate," variations of such words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect Longport's actual results include, among others,
uncertainties as to the Company's ability to manage potential
problems, delays or anticipated expenses, including problems, delays
or expenses involving manufacturing. Readers are cautioned not to
place undue reliance upon these forward-looking statements that speak
only to the date of this release. Reference is made to Longport's 2004
annual report on Form 10-K filed with the Securities and Exchange
Commission for a more definitive description of such factors.
Longport, Inc. undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the
occurrence of unanticipated events.